SymBio Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.2%.

Top 16 shareholders own 12.74% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.01%	Rakuten Investment Management, Inc.	1,836,600	US$3.0m	0%	0.25%
2.57%	Fuminori Yoshida	1,179,700	US$1.9m	0%	no data
1.33%	Norihiro Kuroda	610,000	US$991.2k	0%	no data
0.94%	Sukenori Ito	430,000	US$698.7k	0%	no data
0.65%	Daisuke Gomi	300,000	US$487.5k	0%	no data
0.59%	Matsui Securities Co. Ltd., Asset Management Arm	271,000	US$440.4k	0%	0.31%
0.56%	SBI Holdings Inc., Asset Management Arm	255,980	US$415.9k	0%	0.02%
0.48%	Toshitaka Kashiwabara	220,025	US$357.5k	0%	no data
0.34%	Daiwa Asset Management Co., Ltd.	155,250	US$252.3k	0%	no data
0.27%	Sumitomo Mitsui Financial Group Inc., Asset Management Arm	125,200	US$203.4k	0%	no data
0.26%	Tsuguyuki Fujimoto	121,000	US$196.6k	0%	no data
0.26%	Hiroshi Nishioka	120,000	US$195.0k	0%	no data
0.25%	Hiromi Toshishige	115,800	US$188.2k	0%	no data
0.13%	State Street Global Advisors, Inc.	61,000	US$99.1k	1.33%	no data
0.049%	Shigetoshi Matsumoto	22,500	US$36.6k	0%	no data
0.032%	Dimensional Fund Advisors LP	14,712	US$23.9k	-42.3%	no data